Searched for
BULK DRUGS PLANT
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Hyderabad laid-off techie turns 'ganja engineer' on terrace; 17 plants that could yield 10 kg seizedExcise officials in Hyderabad arrested a former software engineer for cultivating cannabis plants on his terrace. Investigators linked the ...
- Plant for production of Penicillin G & Clavulanic acid to start soon: Department of PharmaceuticalsThe Department of Pharmaceuticals has announced that India will soon start producing Clavulanic Acid, a key ingredient in the antibiotic Au...
- Govt approves eight companies under PLI scheme for manufacturing medical devicesWith this the total applications approved under both rounds aggregate to 21 applicants with committed investment of Rs 1,059.33 crore and e...
- JB Chemicals to move higher judiciary against NGT orderJB Chemicals and Pharmaceuticals plans to appeal the orders passed by National Green Tribunal against the company's Panoli bulk drugs plant...
- JB Chemicals to file review plea in NGT against plant closureConsequently, the NGT had also directed the company to close down the activities at the said plant within four weeks.
- Will challenge NGT order to close down Gujarat plant: JB Chemicals & PharmaceuticalsConsequently, the NGT has also "directed the company to close down the activities at the said plant within four weeks", it added.
- Drug Controller General of India to inspect bulk drug plants exporting to EUDCGI is readying a plan to check if domestic bulk drug facilities that export to the European Union comply with WHO-prescribed norms.
- Ranbaxy may wind up Mohali unitThe company sources products from local units now; may outsource manufacturing.
- Bal Pharma to raise $20 mn for expansionBangalore-based pharma company Bal Pharma is planning to raise $20 million for capacity expansion and asset acquisition.
Load More
